RAM
ABBV icon

RWC Asset Management’s AbbVie ABBV Stock Holding History

RWC Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,126
Closed -$680K – 161
2026
Q1 		$680K Buy
3,126
+1,205
+63% +$267K 0.03% 125
2025
Q4 		$439K Sell
1,921
-187
-9% -$42.6K 0.02% 140
2025
Q3 		$488K Buy
2,108
+586
+39% +$119K 0.02% 146
2025
Q2 		$283K Sell
1,522
-36
-2% -$6.69K 0.01% 159
2025
Q1 		$326K Buy
1,558
+23
+1% +$4.47K 0.02% 139
2024
Q4 		$273K Buy
+1,535
New +$282K 0.01% 138

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RWC Asset Management's ABBV Position: Q2 2026 in Review

RWC Asset Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 3,126 shares — an estimated $680K sold.

RWC Asset Management first reported a position in ABBV in Q4 2024 and held it in 6 quarters. The position peaked at $680K in Q1 2026. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • RWC Asset Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • RWC Asset Management sold 3,126 AbbVie shares in Q2 2026, an estimated $680K.
  • RWC Asset Management first reported a position in AbbVie in Q4 2024 and held it in 6 quarters.
  • RWC Asset Management's AbbVie position peaked at $680K in Q1 2026.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on RWC Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.